Subcutaneous pyelovesical bypass graft (SPBG) is a urinary diversion treatment option for ureteral obstruction. Initially its use was limited to palliative care patients. However, the indication profile has been extended to selected patients with benign conditions causing ureteral obstruction and hydronephrosis. Occlusion of SPBGs is rarely reported and mostly related to infections. We describe the clinical case of a patient with SPBG after iatrogenic ureteral stricture who was not suitable for other reconstructive treatment forms due to distinct retroperitoneal scarring after multiple previous surgeries. Several months after the SPBG insertion, the patient developed complete occlusion of the system with uric acid stone material. Sufficient endoscopic intervention was not feasible. After forced chemolitholysis, the stone mass could be completely dissolved. Since then the patient has remained symptom-free.

Keywords:
Uric acid stone, Ureteral stricture, Subcutaneous pyelovesical bypass graft, Detour® system
1.
Lloyd SN, Tirukonda P, Biyani CS, Wah TM, Irving HC: The Detour extra-anatomic stent - a permanent solution for benign and malignant ureteric obstruction? Eur Urol 2007;52:193-198.
2.
Bynens BG, Ampe JF, Denys H, Oyen PM: Case report: relief of acute obstruction of the Detour subcutaneous pyelovesical bypass. J Endourol 2006;20:669-671.
3.
Haddad N, Andonian S, Anidjar M: Simultaneous bilateral subcutaneous pyelovesical bypass as a salvage procedure in refractory retroperitoneal fibrosis. Can Urol Assoc J 2013;7:E417-E420.
4.
Desgrandchamps F, Cussenot O, Meria P, Cortesse A, Teillac P, Le Duc A: Subcutaneous urinary diversions for palliative treatment of pelvic malignancies. J Urol 1995;154:367-370.
5.
Desgrandchamps F, Duboust A, Teillac P, Idatte JM, Le Duc A: Total ureteral replacement by subcutaneous pyelovesical bypass in ureteral necrosis after renal transplantation. Transpl Int 1998;11(suppl 1):S150-S151.
6.
Azhar RA, Hassanain M, Aljiffry M, Aldousari S, Cabrera T, Andonian S, Metrakos P, Anidjar M, Paraskevas S: Successful salvage of kidney allografts threatened by ureteral stricture using pyelovesical bypass. Am J Transplant 2010;10:1414-1419.
7.
Muller CO, Meria P, Desgrandchamps F: Long-term outcome of subcutaneous pyelovesical bypass in extended ureteral stricture after renal transplantation. J Endourol 2011;25:1389-1392.
8.
Jabbour ME, Desgrandchamps F, Angelescu E, Teillac P, Le Duc A: Percutaneous implantation of subcutaneous prosthetic ureters: long-term outcome. J Endourol 2001;15:611-614.
9.
Burgos FJ, Bueno G, Gonzalez R, Vazquez JJ, Diez-Nicolás V, Marcen R, Fernández A, Pascual J: Endourologic implants to treat complex ureteral stenosis after kidney transplantation. Transplant Proc 2009;41:2427-2429.
10.
Mechlin C, Kalorin C, Asplin J, White M: Splenda® improves tolerance of oral potassium citrate supplementation for prevention of stone formation: results of a randomized double-blind trial. J Endourol 2011;25:1541-1545.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.